Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A site-wide NIH transition notice appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:26:12.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The site revision indicator changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:40:47.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, indicating an access/permission issue that prevents viewing the record.
    Difference
    19%
    Check dated 2026-09-23T00:24:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays the updated platform revision (v3.7.0) in place of the previous v3.6.6, indicating a site-wide update without altering the study details.
    Difference
    0.1%
    Check dated 2026-09-15T23:53:07.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page footer now displays a new revision tag (v3.6.6) and the previous revision tag (v3.6.5) along with related attribution text were removed. This is a minor administrative update to site metadata and does not change the study details.
    Difference
    0.2%
    Check dated 2026-09-01T20:03:50.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, signaling a new version of the page. This update is administrative and does not alter the study content presented.
    Difference
    0.1%
    Check dated 2026-08-11T15:48:44.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.